Carmuta 150 mg Injection

Description

Carmuta 150 mg Injection is an anticancer agent which is used in the treatment of cancer of the female reproductive system. It should be used under the supervision of a qualified physician. Close monitoring of kidney function and blood cell count are necessary while receiving this medication.

Side effects

Major & minor side effects for Carmuta 150 mg Injection

In addition to its intended effect, Carmuta 150 mg Injection may cause some unwanted effects too. In such cases, you must seek medical attention immediately.

Pain at the injection site severe

Low WBC and Platelet count severe

Fever and chills severe

Difficult or painful urination severe

Skin rash severe

Unusual bleeding severe

Tingling or numbness of the hands and feet severe

Blurred vision severe rare

Ringing or buzzing in the ears severe rare

Nausea and Vomiting

Diarrhea

Loss of appetite

severe

Contact your doctor immediately if any of these symptoms are experienced on a regular basis.

rare

Observed in a small fraction of population.

This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.

Show more

Highlights

Commonly asked questions for Carmuta 150 mg Injection

Onset of action

The peak effect of this medicine can be observed in 2 to 4 hours after intravenous injection.

Duration of effect

The effect of this medicine lasts for an average duration of 24 hours.

Safe with alcohol?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?

No habit forming tendencies were reported.

Usage in pregnancy?

This medicine is not recommended for pregnant women.

Usage while breast-feeding?

This medicine is not recommended in breastfeeding women.

What is it prescribed for?

Uses of Carmuta 150 mg Injection

Ovarian Cancer

Carmuta 150 mg Injection is used in the treatment of cancer that affects the ovaries.

Show more

When not to use?

Contraindications for Carmuta 150 mg Injection

Allergy

Not recommended in patients with known allergy to Carmuta 150 mg Injection or other platinum-containing compounds.

Significant bleeding

Not recommended in patients with the bleeding disorder.

Severe myelosuppression

Not recommended in patients with low white blood cell and platelet count.

Show more

Dosage

Missed / Overdose instructions

Missed Dose

Overdose

It is advised not to miss any dose. If you missed any dose, you should contact your doctor immediately.

Show more

Interactions

Whenever you take more than one medicine, or mix it with certain foods or beverages, you’re at risk of a drug interaction.

Interaction with Alcohol

Description

- Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

- Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

Clozapine

severe

Vancomycin

moderate

Atorvastatin

moderate

Live vaccines

severe

Other Interactions

Disease

Food

Lab Test

Disease

Information not available.

This is not an exhaustive list of interactions. Always inform your doctor beforehand about your medical history and current medications.

Show more

General Instructions

This medicine is given in multiple cycles. It is important to receive the every scheduled dose and make a note of next scheduled dose. Close monitoring of blood cells counts and kidney function.

Show more

Warnings

Warnings for special population

Pregnancy

This medicine is not recommended for pregnant women.

Breast-feeding

This medicine is not recommended in breastfeeding women.

Black box warnings

Carboplatin injection should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Appropriate management of therapy and complications is possible only when adequate treatment facilities are readily available.
Bone marrow suppression is dose related and may be severe, resulting in infection and/or bleeding. Anemia may be cumulative and may require transfusion support. Vomiting is another frequent drug-related side effect.
Anaphylactic-like reactions to carboplatin have been reported and may occur within minutes of carboplatin administration. Epinephrine, corticosteroids, and antihistamines have been employed to alleviate symptoms.

General warnings

Impaired kidney function

This medicine may cause severe kidney injury. The risk may increase if taken with aminoglycoside antibiotics. Close monitoring of serum creatinine, urea, and sodium levels is necessary. Do not administer this medicine more than once every 3 to 4 weeks.

Hearing impairment

This medicine may cause the hearing problem which is more common in children. Audiometric testing should be performed before initiating the treatment and also before every dose. Any symptoms of the hearing problem should be reported to the doctor.

Allergy

This medicine may cause serious skin reactions. Discontinue the treatment if any symptoms of allergy appear and do not restart.

Blood cell count

This medicine may lower the white blood cells and platelets. Close monitoring of blood cell count is necessary. Do not start the treatment if the cell count is low.

Infections

The chances of occurring infections are more in patients receiving this medicine. Hold the chemotherapy and start with the broad-spectrum antibiotics if there are any signs and symptoms of fever. Close monitoring of the body temperature and the blood cell count is necessary.

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.